A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...

When a person’s asthma is severe or isn’t managed well by typical protocols, they may be a good candidate for pulmonary ...

Treatment for asthma and COPD exacerbations have not changed ... we'll make sure that families everywhere never face a lung condition without the best treatment and care." More information ...

A new study on a drug widely prescribed for asthma is binding itself to receptors ... Earlier research also found that the medications penetrated the brains of rats. However, more data is needed ...

The cost of medication to treat asthma, the chronic lung disease, is stopping one in six US adults from taking their medication as it has been prescribed, researchers warned Monday. Furthermore ...

Factors that were associated with cost-related medication nonadherence included demographics and comorbidities. (HealthDay News) — For adults with asthma, the prevalence of cost-related ...

More information: Chun-Tse Hung et al, Cost-related non-adherence to medications among adults with asthma in the U.S., 2011–2022, Thorax (2024).DOI: 10.1136/thorax-2024-221778 Emily L Graul et ...